13073_2017_407_MOESM1_ESM.pdf (10.22 MB)
Additional file 1: Figure S1. of Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance
journal contribution
posted on 2017-02-10, 05:00 authored by David Duffy, Aleksandar Krstic, Melinda Halasz, Thomas Schwarzl, Anja Konietzny, Kristiina Iljin, Desmond Higgins, Walter KolchAdditional RT-qPCR, RNA-seq and patient survival curve data. Figure S2 Additional GO term analysis for the SY5Y-MYCN RNA-seq data. Figure S3 Additional ITR analysis for the SY5Y-MYCN RNA-seq data. Figure S4 Additional data showing that RA and MYCN overexpression drive opposing activation dynamics of their downstream transcriptional regulators. Figure S5 Additional TGF-β/SMAD MYCN ChIP-seq and interactome data. Figure S6 Additional data showing TGF-β pathway components targeted by the small molecule kartogenin are predictive of neuroblastoma patient outcome. Figure S7 Additional kartogenin and retinoic acid cell viability and apoptosis data. (PDF 10467 kb)
Funding
Science Foundation Ireland
History
Usage metrics
Categories
Keywords
NeuroblastomaKartogenin (KGN)RepSoxMYC (c-MYC)DifferentiationmRNA sequencing (mRNA-seq)ChIP sequencing (ChIP-seq)Transforming growth factor beta (TGF-β) signallingInteraction proteomicsPrecision medicineGenome medicineWnt β-catenin signallingCancerSystems medicineNeuronal differentiationDifferentiation therapy
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC